Akebia Therapeutics, Inc. - COMMON STOCK (AKBA)

CUSIP: 00972D105

Q1 2022 13F Holders as of 31 Mar 2022

Holder snapshot 7 signals
Share change
-15,624,829
Put/Call ratio
61%
SEC-reported price per share
$0.72
Number of holders
115
Value change
-$32,826,439
Number of buys
52
Open additional details 1 more signal available
Number of sells
69
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
270,093,163

Security key

00972D105

Report period

Q1 2022

Institutions

115

Top holders

10

Ownership snapshot

Top reported holders of AKBA - Akebia Therapeutics, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BlackRock Finance, Inc.
Disclosed value leader
BlackRock Finance, Inc.
Comparable rows
0/15
Latest evidence
31 Dec 2021
13F Highest disclosed value: $31,919,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

BlackRock Finance, Inc. has the largest disclosed position value at $31.92M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BlackRock Finance, Inc.'s linked filing trail.
Disclosed position value Top 5
BlackRock Finance, Inc. $31.92M
VANGUARD GROUP INC $29.91M
STATE STREET CORP $26.54M
Nantahala Capital Management, LLC $11.12M
Alerce Investment Management, L.P. $10.52M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$31,919,000
14,124,215 shares
— 31 Dec 2021
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$29,914,000
13,235,669 shares
— 31 Dec 2021
STATE STREET CORP
13F
Company
13F
—
denominator unverified
$26,540,000
11,743,461 shares
— 31 Dec 2021
Nantahala Capital Management, LLC
13F
Company
13F
—
denominator unverified
$11,116,000
4,918,565 shares
— 31 Dec 2021
Alerce Investment Management, L.P.
13F
Company
13F
—
denominator unverified
$10,515,000
4,652,561 shares
— 31 Dec 2021
MARSHALL WACE, LLP
13F
Company
13F
—
denominator unverified
$10,114,000
4,475,138 shares
— 31 Dec 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
115
Shares
81,183,875
Rows available
115
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2022 vs Q1 2022 Across Filers

Q1 2022 holders
115
Q1 2022 holders
115
Holder diff
0
Investor Q1 2022 Shares Q1 2022 Shares Share Diff Share Chg % Q1 2022 value Q1 2022 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .